89 results
Page 5 of 5
6-K
EX-99.1
w94md
13 May 20
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment and the BLU-5937 Program
7:00am
6-K
EX-99.1
qd2bu2yp
5 May 20
BELLUS Health Announces Change to Annual and Special Shareholder Meeting Format
5:28pm
6-K
EX-99.1
i8q89i2pa5pcvqj2
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
6-K
EX-99.2
enudju3f
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
6-K
EX-99.1
vbg9i
7 Apr 20
Bellus HEALTH 2019 ANNUAL REPORT
9:59am
6-K
EX-99.1
js5om
6 Apr 20
BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough
5:02pm
6-K
EX-99.2
t7pxdni
23 Mar 20
Current report (foreign)
8:11am
SUPPL
9db4y
23 Mar 20
Supplemental materials (foreign)
7:06am
6-K
EX-99.1
35r4zon ntztqs2cgod2
19 Mar 20
BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am